van Gaalen; Marcel

Patent Applications and Registrations

Patent applications and USPTO patent grants for van Gaalen; Marcel.The latest application filed is for "oxindole derivatives carrying a piperidyl-substituted azetidinyl substituent and use thereof for treating vasopressine-related diseases".

Company Profile

0.13.15

van Gaalen; Marcel - Ludwigshafen DE
Van Gaalen; Marcel - Gottingen DE
van Gaalen; Marcel - Wiesbaden DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors Grant 10,100,048 - Turner , et al. October 16, 2	2018-10-16
Oxindole derivatives carrying an amine-substituted piperidyl-acetidinyl substituent and use thereof for treating vasopressine-related diseases Grant 9,862,704 - Geneste , et al. January 9, 2	2018-01-09
Oxindole derivatives carrying a piperidyl-substituted azetidinyl substituent and use thereof for treating vasopressine-related diseases Grant 9,840,495 - Geneste , et al. December 12, 2	2017-12-12
Oxindole compounds carrying a nitrogen-bound spiro substituent and use thereof for treating vasopressin-related diseases Grant 9,688,678 - Geneste , et al. June 27, 2	2017-06-27
Oxindole derivatives carrying an oxetane substituent and use thereof for treating vassopressin-related diseases Grant 9,657,002 - Jantos , et al. May 23, 2	2017-05-23
Fused heterocyclic or carbocyclic compounds carrying a substituted cycloaliphatic radical and use thereof for treating vasopressin-related diseases Grant 9,617,226 - Braje , et al. April 11, 2	2017-04-11
Oxindole Derivatives Carrying A Piperidyl-substituted Azetidinyl Substituent And Use Thereof For Treating Vasopressine-related Diseases App 20170008875 - GENESTE; Herve ; et al.	2017-01-12
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors Grant 9,540,370 - Turner , et al. January 10, 2	2017-01-10
Oxindole Derivatives Carrying An Amine-substituted Piperidyl-azetidinyl Substituent And Use Thereof For Treating Vasopressine-related Diseases App 20170001982 - GENESTE; Herve ; et al.	2017-01-05
Oxindole compounds carrying a CO-bound spiro substituent and use thereof for treating vasopressin-related diseases Grant 9,527,856 - Braje , et al. December 27, 2	2016-12-27
Heterocyclic Compounds And Their Use As Glycogen Synthase Kinase-3 Inhibitors App 20160194320 - Turner; Sean Colm ; et al.	2016-07-07
Oxindole Derivatives Carrying An Oxetane Substituent Anduse Thereof For Treating Vasopressin-related Diseases App 20160168135 - Jantos; Katja ; et al.	2016-06-16
Fused Heterocyclic Or Carbocyclic Compounds Carrying A Substituted Cycloaliphatic Radical And Use Thereof For Treating Vasopressin-related Diseases App 20160068494 - Braje; Wilfried ; et al.	2016-03-10
Oxindole derivatives carrying an oxetane substituent and use thereof for treating vasopressine-related diseases Grant 9,273,036 - Jantos , et al. March 1, 2	2016-03-01
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors Grant 9,266,855 - Turner , et al. February 23, 2	2016-02-23
Heterocyclic Compounds And Their Use As Glycogen Synthase Kinase-3 Inhibitors App 20160016932 - Turner; Sean Colm ; et al.	2016-01-21
Oxindole Compounds Carrying A Co-bound Spiro Substituent And Use Thereof For Treating Vasopressin-related Diseases App 20150344489 - Braje; Wilfried ; et al.	2015-12-03
Oxindole Compounds Carrying A Nitrogen-bound Spiro Substituent And Use Thereof For Treating Vasopressin-related Diseases App 20150329551 - Geneste; Herve ; et al.	2015-11-19
Heterocyclic Compounds And Their Use As Glycogen Synthase Kinase-3 Inhibitors App 20150274724 - Turner; Sean Colm ; et al.	2015-10-01
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors Grant 9,090,592 - Turner , et al. July 28, 2	2015-07-28
Oxindole Derivatives Carrying An Oxetane Substituent and use thereof for Treating Vasopressine-Related Diseases App 20140343074 - Jantos; Katja ; et al.	2014-11-20
Oxindole Derivatives Carrying An Oxetane Substituent and Use Thereof For Treating Vassopressin-Related Diseases App 20140315918 - Jantos; Katja ; et al.	2014-10-23
Method For Selecting Or Identifying A Subject For V1B Antagonist Therapy App 20130245038 - Katz; David ; et al.	2013-09-19
Heterocyclic Compounds And Their Use As Glycogen Synthase Kinase-3 Inhibitors App 20120172376 - Turner; Sean Colm ; et al.	2012-07-05
Heterocyclic Compounds And Their Use As Glycogen Synthase Kinase-3 Inhibitors App 20120077840 - Turner; Sean Colm ; et al.	2012-03-29
Use Of Substituted Oxindole Derivatives For The Treatment And Prophylaxis Of Pain App 20110059983 - Braje; Wilfried ; et al.	2011-03-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.